Recent Updates
Recently added Catalysts
AKAN Positive Sentiment Score: 75/100

Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States Toronto, Ontario

Key Takeaway: Akanda Corp. expresses support for the U.S. government's potential reclassification of cannabis from Schedule I to Schedule III, highlighting the importance of modernizing cannabis policies. The interim CEO emphasized the benefits of a science-led, public-health approach, which could enhance medical research and consumer safety while addressing illicit supply chains. The company advocates for reforms focused on measurable outcomes similar to Canada's comprehensive cannabis legislation. Akanda aims to provide high-quality cannabis products and improve wellness through its business operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Potential reclassification of cannabis could enhance medical research.
  • Government focus on a science-led, public-health framework.
  • Encouragement for responsible regulation and consumer safety.
  • Comparison to Canada's successful cannabis regulation model.

Full Press Release Details

Akanda Corp. Welcomes Momentum Towards Cannabis
Reform in the United States
Toronto, Ontario, December 18, 2025 (Business
Wire) - Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) applauds the recent reports that US President
Donald Trump and his administration are considering changes and the reclassification of federal cannabis policy in the USA, including
potential rescheduling of cannabis from Schedule I to Schedule III. Schedule III drugs are considered to have a medical value and a lower
abuse potential as defined by the Drug Enforcement Administration.
"Cannabis policies are long overdue for
modernization," said Interim CEO Katie Field. "The US Administration is taking steps to treat cannabis through a science-led,
public-health framework which has the potential to accelerate medical research, improve consumer safety, and help move regulated markets
further away from the risks of the illicit supply chain."
This effort mirrors, in spirit if not in scope,
the pathway Canada forged with its Cannabis Act, which came into force on October 17, 2018 and created a comprehensive legal and regulatory
framework for both adult-use and medical cannabis nationwide, shifting cannabis out of prohibition entirely and tightly regulating production,
distribution, sale, possession and public health protections - a model policymakers south of the border often point to when discussing
how to reconcile federal and state law and develop standards for responsible legal markets.
Akanda encourages policymakers to keep reforms
while they are under consideration focused on measurable outcomes: expanding medical research, protecting public health, supporting responsible
regulation, and moving consumers away from illicit supply chains.
Akanda Corp., through its cannabis subsidiaries
with operations in Canada, is dedicated to cultivating and distributing high-quality cannabis and wellness products that improve lives.
Its mission is to provide safe, reliable, and accessible cannabis products to consumers worldwide while promoting sustainable business
Forward-Looking Statements
This press release contains
"forward-looking statements." Such statements which are not purely historical (including, but not limited to statements that
contain words such as "will," "believes," "plans," "anticipates," "expects,"
"intends," "would," "could" and "estimates") are forward-looking statements and include
any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the consummation
Important factors, among others, that may affect
actual results or outcomes include: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii)
failure to realize the anticipated benefits of the recent acquisition of FTF by Akanda; (iii) the limited operating history of each of
Akanda and FTF; (iv) the ability of Akanda and its subsidiaries (collectively, "Akanda Group") to grow and manage growth effectively;
(v) the ability of Akanda Group to execute their business plans; (vi) estimates of the size of the markets for Akanda Group's products
and services; (vii) the rate and degree of market acceptance of Akanda Group's products and services; (viii) Akanda Group's ability to
identify and integrate acquisitions; (ix) future investments in technology and operations; (x) potential litigation involving Akanda Group;
(xi) risks relating to the uncertainty of projected financial information; (xii) the effects of competition on Akanda Group's businesses;
(xiii) developments and changes in laws and regulations; (xiv) the impact of significant investigative, regulatory or legal proceedings;
(xv) general economic and market conditions impacting demand for Akanda Group's products and services; (xvi) the ability to meet Nasdaq's
listing standards; (xvii) the ability of Akanda to raise capital, and to issue equity or equity-linked securities in the future; (xviii)
the ability of Akanda to manage its significant debt load and liabilities; and (xix) such other risks and uncertainties as are discussed
in Akanda's Annual Report on Form 20-F filed with the SEC or in other documents Akanda files from time to time with the SEC. Akanda expressly
disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein
to reflect any change in Akanda's expectations with respect thereto or any change in events, conditions or circumstances on which any
Actual results could
differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of
the date of this press release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons
why actual results could differ from those projected in the forward-looking statements, except as required by law. Although the Company
believes that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance
that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth
herein and should also refer to the risk factors disclosure outlined in the Company's reports and statements filed from time-to-time
with the Securities and Exchange Commission.

Frequently Asked Questions

What recent changes in cannabis policy is Akanda Corp. supporting?

Akanda Corp. supports potential reclassification of cannabis from Schedule I to Schedule III.

How does Akanda Corp. view cannabis policy modernization?

Akanda sees modernization as essential to enhance medical research and consumer safety.

What is Akanda's mission regarding cannabis products?

Akanda aims to provide safe and accessible cannabis products globally.

What does Akanda promote within the cannabis industry?

Akanda promotes sustainable business practices and responsible regulation in cannabis.

What framework does Akanda reference for cannabis regulation?

Akanda references Canada's Cannabis Act as a model for legal cannabis regulation.

Last updated: Dec 18, 2025